NEWPHARMA.DK ApS: Financial statements 2012

CVR: 31431824

Source: annual report 2012, Danish Business Authority

01/10/2011 – 30/09/2012

NEWPHARMA.DK ApS (CVR 31431824) has filed annual accounts for 2012. In 2012, the company reported a gross profit of DKK 393,056.

Gross Profit: DKK 393,056

Official annual report

View the official annual report directly on the page with a Pro subscription.

Keep an eye on NEWPHARMA.DK ApS

Get notified instantly about new financial statements, ownership changes, management changes and status changes.

Set up monitoring

Events in 2012

Auditor steps down at NEWPHARMA.DK ApSMar 12, 2012

As of March 12, 2012, TIMEVISION FREDERIKSBERG REGISTRERET REVISIONSAKTIESELSKAB has stepped down as auditor of NEWPHARMA.DK ApS.

About NEWPHARMA.DK ApS

NEWPHARMA.DK ApS was a Danish company of the type Anpartsselskab based in Hellerup, founded in 2008. The company has been dissolved on 16 November 2015. The company was registered under the industry Forskning og eksperimentel udvikling indenfor bioteknologi. In 2013, the company reported a gross profit of DKK 1,133,770 and a net result of DKK 1,020,452. Equity in the 2013 report amounted to DKK 1,639,292.

Source: annual report 2013, Danish Business Authority

Other financial years

2013